Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Allscripts Healthcare Solutions

Related MDRX
Benzinga's Top Downgrades
RBC Capital Downgrades Allscripts Healthcare Solutions To Sector Perform

In a report published Friday, Jefferies & Company reiterated its Hold rating on Allscripts Healthcare Solutions (NASDAQ: MDRX), and raised its price target from $10.50 to $13.00.

Jefferies noted, “Dismal 3Q results were attributed to customer hesitation on MDRX's a) corporate future and b) NT product future. The acknowledgment of a deal process puts a floor in the stock. Maybe even drives some upside. Many long-awaited releases go GA this month, but NT impact on bookings is questionable. 2012 guidance was withdrawn. A lower go-forward tax rate and share count offset nearly all of our reduction in 2013 pre-tax income.”

Allscripts Healthcare Solutions closed on Thursday at $12.26.

Latest Ratings for MDRX

DateFirmActionFromTo
Nov 2014RBC CapitalDowngradesOutperformSector Perform
Nov 2014Evercore PartnersDowngradesBuyHold
Nov 2014Credit SuisseMaintainsOutperform

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (MDRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters